EPIWORLD will hold a board meeting on 28 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026. Additional corporate matters may also be addressed during the session. The meeting was confirmed via an announcement issued on 18 August 2026 by Chairman and Executive Director Dr. Zhao Jianhui.
The current Board comprises two executive directors (Dr. Zhao Jianhui and Ms. Pan Menghan), two non-executive directors (Ms. Xie Jieping and Ms. Guo Danxia) and three independent non-executive directors (Dr. Kang Junyong, Dr. Liao Yi and Dr. Su Xinlong).
Investors will gain insight into EPIWORLD’s mid-year performance when the Board releases the approved interim results following the scheduled meeting.